ABBVIE INC.
€182.94
EUR
Last updated on --.
24h volume1.68M
24h highest187.68 EUR
24h lowest182.64 EUR
24h Price movement-1.46%
ABBV recent prices
24 Hours
-1.46%-€2.712
30 days
+9.94%+€16.88
60 days
+3.63%+€6.540
90 days
-4.37%-€8.540
Key data
Previous close185.65 EUR
Market cap322.84B EUR
Volume1.68M
P/E ratio104.050000
Dividend yield (TTM)0.03%
Dividend amount1.4890 EUR
Next ex-dividend dateApr 15, 2026
Next payment dateMay 15, 2026
EPS diluted (TTM)1.7558 EUR
Net income (FY)3.13B EUR
Revenue (FY)54.07B EUR
Last report dateMay 8, 2026
About ABBVIE INC.
HeadquartersNORTH CHICAGO
Employees (FY)57.00K
Revenue per employee (FY)948.57K EUR
Net income per employee (FY)54.98K EUR
Listed onNew York Stock Exchange
ABBV conversion tables
 |  |
|---|---|
| 0.5 ABBV | 91.47 EUR |
| 1 ABBV | 182.94 EUR |
| 5 ABBV | 914.72 EUR |
| 10 ABBV | 1,829.45 EUR |
| |
|---|---|
| 0.5 EUR | 0.0027331 ABBV |
| 1 EUR | 0.0054661 ABBV |
| 5 EUR | 0.027331 ABBV |
| 10 EUR | 0.054661 ABBV |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ABBV is trading at €182.94, -1.46% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ABBV stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ABBV is currently trading at €182.94, -1.46% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ABBV price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ABBV's P/E ratio is currently 104.050000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ABBV; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ABBV's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
ABBVIE INC.'s market cap is currently 322.84B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.68M
24h highest187.68 EUR
24h lowest182.64 EUR
24h Price movement-1.46%
Start trade with ABBV Perpetual
Sign up to trade